Neuronetics
STIM

Neuronetics (STIM) analyst forecast and price target

Analyst forecast

Buy

Consensus of 3 analyst ratings

Buy
3
Hold
0
Sell
0

Recent analyst ratings

FirmActionRatingPrice targetDate
BTIGMaintainedBuy$6.00 from $5.00Aug 11, 2026
BTIGInitiated CoverageBuy$5.00Jul 20, 2026
Canaccord GenuityMaintainedBuy$3.00 from $7.00Mar 19, 2026
Canaccord GenuityMaintainedBuy$7.00 from $8.00Aug 6, 2025
Citizens Capital MarketsMaintainedMarket Outperform$7.00 from $3.00Mar 5, 2025
Canaccord GenuityMaintainedBuy$8.00 from $5.00Mar 5, 2025
JMP SecuritiesMaintainedMarket Outperform$3.00 from $7.00Aug 14, 2024
Canaccord GenuityMaintainedBuy$3.00 from $6.00Aug 13, 2024
William BlairDowngradedOutperform → Market PerformAug 12, 2024
William BlairUpgradedMarket Perform → OutperformMay 14, 2024
Piper SandlerMaintainedOverweight$8.00 from $7.00Mar 6, 2024
JMP SecuritiesMaintainedMarket Outperform$12.00May 10, 2023
Canaccord GenuityMaintainedBuy$7.00 from $9.00Mar 8, 2023
JMP SecuritiesMaintainedMarket Outperform$12.00Mar 8, 2023

Frequently asked questions

  • Is STIM a buy, sell, or hold?

    Analysts covering Neuronetics currently average a Buy rating: 3 buy, 0 hold and 0 sell, from 3 analysts. Ratings reflect analyst opinion, not investment advice.

  • What is the latest analyst rating on STIM?

    On Aug 11, 2026, BTIG maintained Neuronetics at Buy with a price target of $6.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.